These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1285 related items for PubMed ID: 32087217

  • 1. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
    Dai Y, Wang S, Chang S, Ren D, Shali S, Li C, Yang H, Huang Z, Ge J.
    J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
    [Abstract] [Full Text] [Related]

  • 2. M2 Macrophage-Derived Exosomes Regulate Myocardial Ischemia-Reperfusion And Pyroptosis Via ROS/NLRP3 Pathway.
    Hu H, Qi L, Ren C, Yan S.
    Heart Surg Forum; 2022 Sep 28; 25(5):E698-E708. PubMed ID: 36317904
    [Abstract] [Full Text] [Related]

  • 3. Diannexin alleviates myocardial ischemia-reperfusion injury by orchestrating cardiomyocyte oxidative damage, macrophage polarization and fibrotic process by TLR4-NF-kB-mediated inactivation of NLRP3 inflammasome.
    Zhang L, Zhao S, Wang Y.
    Int Immunopharmacol; 2024 Mar 30; 130():111668. PubMed ID: 38417368
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
    Zhang X, Du Q, Yang Y, Wang J, Dou S, Liu C, Duan J.
    Biomed Pharmacother; 2017 Jul 30; 91():1042-1052. PubMed ID: 28525945
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Formononetin ameliorates myocardial ischemia/reperfusion injury in rats by suppressing the ROS-TXNIP-NLRP3 pathway.
    Wang DS, Yan LY, Yang DZ, Lyu Y, Fang LH, Wang SB, Du GH.
    Biochem Biophys Res Commun; 2020 May 07; 525(3):759-766. PubMed ID: 32145915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X7R/NLRP3 inflammasome.
    Wu Y, Zhang Y, Zhang J, Zhai T, Hu J, Luo H, Zhou H, Zhang Q, Zhou Z, Liu F.
    J Mol Cell Cardiol; 2020 Feb 07; 139():75-86. PubMed ID: 31982429
    [Abstract] [Full Text] [Related]

  • 11. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
    Liu Y, Lian K, Zhang L, Wang R, Yi F, Gao C, Xin C, Zhu D, Li Y, Yan W, Xiong L, Gao E, Wang H, Tao L.
    Basic Res Cardiol; 2014 Feb 07; 109(5):415. PubMed ID: 25015733
    [Abstract] [Full Text] [Related]

  • 12. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages.
    Liu Y, Lou G, Li A, Zhang T, Qi J, Ye D, Zheng M, Chen Z.
    EBioMedicine; 2018 Oct 07; 36():140-150. PubMed ID: 30197023
    [Abstract] [Full Text] [Related]

  • 13. Aesculin suppresses the NLRP3 inflammasome-mediated pyroptosis via the Akt/GSK3β/NF-κB pathway to mitigate myocardial ischemia/reperfusion injury.
    Xu XN, Jiang Y, Yan LY, Yin SY, Wang YH, Wang SB, Fang LH, Du GH.
    Phytomedicine; 2021 Nov 07; 92():153687. PubMed ID: 34482222
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury.
    El-Sisi AEE, Sokar SS, Shebl AM, Mohamed DZ, Abu-Risha SE.
    Toxicol Appl Pharmacol; 2021 Jan 01; 410():115340. PubMed ID: 33264646
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca2+ overload via the microRNA-346-3p/CaMKIId axis.
    Zheng X, Li J, Fan Q, Zhao X, Chen K.
    Int J Cardiol; 2021 Sep 01; 338():185-195. PubMed ID: 33731281
    [Abstract] [Full Text] [Related]

  • 18. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
    Zhang J, Huang L, Shi X, Yang L, Hua F, Ma J, Zhu W, Liu X, Xuan R, Shen Y, Liu J, Lai X, Yu P.
    Aging (Albany NY); 2020 Nov 24; 12(23):24270-24287. PubMed ID: 33232283
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
    Zhou T, Xiang DK, Li SN, Yang LH, Gao LF, Feng C.
    Cell Physiol Biochem; 2018 Nov 24; 49(2):798-815. PubMed ID: 30165354
    [Abstract] [Full Text] [Related]

  • 20. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
    Qiu Z, He Y, Ming H, Lei S, Leng Y, Xia ZY.
    J Diabetes Res; 2019 Nov 24; 2019():8151836. PubMed ID: 30911553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.